KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Royalty Pharma (RPRX) Interest & Investment Income (2019 - 2025)

Royalty Pharma (RPRX) has disclosed Interest & Investment Income for 7 consecutive years, with $7.1 million as the latest value for Q4 2025.

  • Quarterly Interest & Investment Income fell 21.76% to $7.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $33.6 million through Dec 2025, down 29.05% year-over-year, with the annual reading at $33.6 million for FY2025, 29.05% down from the prior year.
  • Interest & Investment Income hit $7.1 million in Q4 2025 for Royalty Pharma, up from $6.9 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $43.9 million in Q4 2022 to a low of $6.5 million in Q4 2023.
  • Historically, Interest & Investment Income has averaged $14.3 million across 5 years, with a median of $11.8 million in 2021.
  • Biggest five-year swings in Interest & Investment Income: soared 672.59% in 2021 and later plummeted 85.18% in 2023.
  • Year by year, Interest & Investment Income stood at $10.6 million in 2021, then surged by 312.19% to $43.9 million in 2022, then tumbled by 85.18% to $6.5 million in 2023, then skyrocketed by 39.03% to $9.0 million in 2024, then dropped by 21.76% to $7.1 million in 2025.
  • Business Quant data shows Interest & Investment Income for RPRX at $7.1 million in Q4 2025, $6.9 million in Q3 2025, and $8.3 million in Q2 2025.